Management

Sheridan Snyder, LLB (Hon) – Chief Executive Officer
Sheridan Snyder has over 40 years experience in creating successful, sustainable companies. He was an original founder of Genzyme Inc. and, most recently, the CEO of Upstate Inc. Mr. Snyder is chairman of BioCatalyst International, the investment and startup management company that is currently the sole investor in MolecularMD. Former companies – with a combined market value of over $18 billion – include Genzyme, the Instapak division of Sealed Air Corp. and Dyax.

Dan Snyder, MBA – President, Chief Operating Officer
Dan Snyder has more than 15 years of experience in the life science research and diagnostic fields supporting the market development of high value products and services to both pharmaceutical and academia clients. Mr. Snyder has worked extensively in supporting new product introductions and rapid market adoption for novel proteomic and genomic technologies. His commitment to customer satisfaction and close interaction with MolecularMD’s assay development laboratory helps to ensure MolecularMD meets or surpasses all client expectations.

Chad Galderisi, D.O. – Vice President of Medical Affairs
Chad Galderisi is one of the scientific founders of MolecularMD with over 10 years of experience in molecular testing and diagnostic surgical pathology. Dr. Galderisi is board certified in Molecular Genetic Pathology and an Adjunct Assistant Professor at Oregon Health and Science University. He currently serves as Laboratory Director and member of the Board of Directors for MolecularMD, Corp.

Nasry Yassa – Vice President of Operations
Nasry Yassa has over 31 years of clinical diagnostics experience. He is currently responsible for managing the day to day operations related to expense, cost and margin control.  Prior to MolecularMD, Mr. Yassa served as Vice President of Operations at Pathway Diagnostics where he managed a multi-disciplinary organization working to identify and in-license novel technology from discovery companies, academia and bio-pharma in all disease areas.

Assay Development

Jin Li, Ph.D., Research Director of Advanced Diagnostics

Sales and Marketing

Inger Larsen, MBA, Director of Business Development (East)
Patrick Jackle, Director of Business Development (West)
Sabita Sankar, Ph.D., Scientific Affairs Liaison (West)
Cindy Spittle, Ph.D., Scientific Affairs Liaison (East)
Katherine Clock, Marketing Program Manager

Licensing

Greg Cox, Ph.D., Licensing Manager 

Clinical Reference Laboratory Operations

Courtney Fuller, Director of Client Services
Kim Anoe, MB (ASCP), Technical Supervisor, Clinical Laboratory

Assay Development

Staci McAdams, Director, Development Program
Thomas D. Yager, Ph.D., Lead IVD Scientist
Kevin Hawkins, Director of Quality and Regulatory Affairs